ScholarIQanswers from OpenAlex

Amplification and overexpression of c‐ erb B‐2, epidermal growth factor receptor , and c‐ met in biliary tract cancers

PaperCitations, authors & open-access status

Amplification and overexpression of c‐ erb B‐2, epidermal growth factor receptor , and c‐ met in biliary tract cancers is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Amplification and overexpression of c‐ erb B‐2, epidermal growth factor receptor , and c‐ met in biliary tract cancers have?

ScholarIQcitation count

Amplification and overexpression of c‐ erb B‐2, epidermal growth factor receptor , and c‐ met in biliary tract cancers has 233 citations in the OpenAlex counts ScholarIQ stores.

When was Amplification and overexpression of c‐ erb B‐2, epidermal growth factor receptor , and c‐ met in biliary tract cancers published?

ScholarIQyear

Amplification and overexpression of c‐ erb B‐2, epidermal growth factor receptor , and c‐ met in biliary tract cancers has 2005 year in the ScholarIQ index.

Open the OpenAlex record →

What is the open-access status of Amplification and overexpression of c‐ erb B‐2, epidermal growth factor receptor , and c‐ met in biliary tract cancers?

ScholarIQoa status

Amplification and overexpression of c‐ erb B‐2, epidermal growth factor receptor , and c‐ met in biliary tract cancers has closed oa status in the ScholarIQ index.

Open the OpenAlex record →

What is the DOI of Amplification and overexpression of c‐ erb B‐2, epidermal growth factor receptor , and c‐ met in biliary tract cancers?

ScholarIQdoi

The DOI for Amplification and overexpression of c‐ erb B‐2, epidermal growth factor receptor , and c‐ met in biliary tract cancers is on the source record.

Open the DOI →

What is the PMID of Amplification and overexpression of c‐ erb B‐2, epidermal growth factor receptor , and c‐ met in biliary tract cancers?

ScholarIQpmid

The PMID for Amplification and overexpression of c‐ erb B‐2, epidermal growth factor receptor , and c‐ met in biliary tract cancers is on the source record.

Open the PMID →

What is the OpenAlex record for Amplification and overexpression of c‐ erb B‐2, epidermal growth factor receptor , and c‐ met in biliary tract cancers?

ScholarIQopenalex

The OpenAlex for Amplification and overexpression of c‐ erb B‐2, epidermal growth factor receptor , and c‐ met in biliary tract cancers is on the source record.

Open the OpenAlex →

Amplification and overexpression of c‐ <i>erb</i> B‐2, <i>epidermal growth factor receptor</i> , and c‐ <i>met</i> in biliary tract cancers

How many citations does Amplification and overexpression of c‐ <i>erb</i> B‐2, <i>epidermal growth factor receptor</i> , and c‐ <i>met</i> in biliary tract cancers have?

When was Amplification and overexpression of c‐ <i>erb</i> B‐2, <i>epidermal growth factor receptor</i> , and c‐ <i>met</i> in biliary tract cancers published?

What is the open-access status of Amplification and overexpression of c‐ <i>erb</i> B‐2, <i>epidermal growth factor receptor</i> , and c‐ <i>met</i> in biliary tract cancers?

What is the DOI of Amplification and overexpression of c‐ <i>erb</i> B‐2, <i>epidermal growth factor receptor</i> , and c‐ <i>met</i> in biliary tract cancers?

What is the PMID of Amplification and overexpression of c‐ <i>erb</i> B‐2, <i>epidermal growth factor receptor</i> , and c‐ <i>met</i> in biliary tract cancers?

What is the OpenAlex record for Amplification and overexpression of c‐ <i>erb</i> B‐2, <i>epidermal growth factor receptor</i> , and c‐ <i>met</i> in biliary tract cancers?

Related on ScholarIQ